Publicacions en col·laboració amb investigadors/es de Hospital Universitari de Bellvitge (27)

2024

  1. Consensus Statement from the Spanish Academy of Dermatology and Venereology (AEDV) Psoriasis Working Group (SWG) and Pediatric Working Group (PWG) on the Management of Pediatric Psoriasis

    Actas Dermo-Sifiliograficas

  2. Efficacy of Risankizumab in Patients with Suboptimal Response or Failure to Ustekinumab: A Multicenter Retrospective Study in Spain

    Dermatologic Therapy, Vol. 2024

  3. Real-world Safety and Efficacy of Risankizumab in Psoriatic Patients: A Multicenter, Retrospective, and Not-interventional Study

    Actas Dermo-Sifiliograficas

  4. Recommendations from the Spanish Academy of Dermatology and Venereology Psoriasis Working Group on the Management of Patients with Cancer and Psoriasis

    Actas Dermo-Sifiliograficas, Vol. 115, Núm. 7, pp. 702-711

2023

  1. Apremilast treatment of plaque psoriasis (PsO) after systemic therapy in Spanish clinical practice: Data from the APPROPRIATE study

    JEADV Clinical Practice, Vol. 2, Núm. 3, pp. 488-501

  2. Selection of Quality Indicators for the Certification of Psoriasis Units: The CUDERMA Project Delphi Consensus Study

    Actas Dermo-Sifiliograficas, Vol. 114, Núm. 10, pp. 865-883

  3. Treatment of Severe Atopic Dermatitis With Upadacitinib in Clinical Practice: Short-Term Efficacy and Safety Results

    Journal of Investigational Allergology and Clinical Immunology

  4. Treatment of severe atopic dermatitis with tralokinumab in clinical practice: short-term effectiveness and safety results

    Clinical and experimental dermatology, Vol. 48, Núm. 9, pp. 991-997

2022

  1. Effectiveness and safety of guselkumab for the treatment of psoriasis in real-world settings at 24 weeks: A retrospective, observational, multicentre study by the Spanish Psoriasis Group

    Dermatologic Therapy, Vol. 35, Núm. 2

2021

  1. Food groups associated with immune-mediated inflammatory diseases: a Mendelian randomization and disease severity study

    European Journal of Clinical Nutrition, Vol. 75, Núm. 9, pp. 1368-1382

2020

  1. Current status of multidisciplinary care in psoriatic arthritis in Spain: NEXUS 2.0 project

    Reumatologia Clinica, Vol. 16, Núm. 1, pp. 24-31

  2. The effectiveness and safety of ixekizumab in psoriasis patients under clinical practice conditions: A Spanish multicentre retrospective study

    Dermatologic Therapy, Vol. 33, Núm. 6

2019

  1. Expert consensus on the persistence of biological treatments in moderate-to-severe psoriasis

    Journal of the European Academy of Dermatology and Venereology, Vol. 33, Núm. 7, pp. 1214-1223

  2. Genetic variation at the glycosaminoglycan metabolism pathway contributes to the risk of psoriatic arthritis but not psoriasis

    Annals of the Rheumatic Diseases, Vol. 78, Núm. 3, pp. 355-364

  3. Safety and effectiveness of conventional systemic therapy and biological drugs in patients with moderate to severe psoriasis and HIV infection: a retrospective multicenter study

    Journal of Dermatological Treatment, Vol. 30, Núm. 5, pp. 461-465

2018

  1. Management of Moderate to Severe Psoriasis in Routine Clinical Practice in Spanish Hospitals

    Actas Dermo-Sifiliograficas, Vol. 109, Núm. 7, pp. 631-642

  2. Standards of care and quality indicators for multidisciplinary care models for psoriatic arthritis in Spain

    Rheumatology International, Vol. 38, Núm. 6, pp. 1115-1124

2017

  1. Modelos de atención multidisciplinar en pacientes con artritis psoriásica en España

    Reumatologia Clinica, Vol. 13, Núm. 2, pp. 85-90

  2. Perception of psoriasis treatment in the outpatient setting: survey of patients and their prescribing physicians

    Journal of Dermatological Treatment, Vol. 28, Núm. 3, pp. 188-199

  3. Psoriasis moderada. Propuesta de definición

    Actas Dermo-Sifiliograficas, Vol. 108, Núm. 10, pp. 911-917